Josh Mandel-Brehm

Chief Executive Officer at CAMP4 Therapeutics Corporation

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
4 years
Director since
2024

4 years of board service in total across 2 boards, counting each seat separately. Longest: ProMIS Neurosciences Inc., 1 year.

1 year · Since 2024
CAMP4 Therapeutics Corporation Director · Chief Executive Officer
1 year · Since 2024

Chief executive roles

CAMP4 Therapeutics Corporation · Chief Executive Officer
Since October 2024

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Oct 15, 2024 CAMP4 Therapeutics Corporation Derivative conversion +605 — —

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.